Abstract:Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder caused by genetic or environmental perturbations during early development. Diagnoses are dependent on the identification of behavioral abnormalities that likely emerge well after the disorder is established, leaving critical developmental windows uncharacterized. This is further complicated by the incredible clinical and genetic heterogeneity of the disorder that is not captured in most mammalian models. In recent years, advancements in stem cell technology have created the opportunity to model ASD in a human context through the use of pluripotent stem cells (hPSCs), which can be used to generate 2D cellular models as well as 3D unguided- and region-specific neural organoids. These models produce profoundly intricate systems, capable of modeling the developing brain spatiotemporally to reproduce key developmental milestones throughout early development. When complemented with multi-omics, genome editing, and electrophysiology analysis, they can be used as a powerful tool to profile the neurobiological mechanisms underlying this complex disorder. In this review, we will explore the recent advancements in hPSC-based modeling, discuss present and future applications of the model to ASD research, and finally consider the limitations and future directions within the field to make this system more robust and broadly applicable.

Generation of an induced pluripotent stem cell line (IPCASi001-A) from an autism spectrum disorder individual without intellectual disability

Generation of Ipsc Line (Gibhi001-A) from a Patient with Autism Spectrum Disorder

Generation of a Human Induced Pluripotent Stem Cell Line (Sjtuxhi002-A) from an Individual with Autism Spectrum Disorder Carrying a Heterozygous Mutation in GRIA2.

Establishment of Induced Pluripotent Stem Cell Line (Zzui009-A) from an Alzheimer's Disease Patient Carrying a PSEN1 Gene Mutation

Generation of Induced Pluripotent Stem Cell Line (Zzui0012-A) from a Patient with Fahr's Disease Caused by a Novel Mutation in SLC20A2 Gene.

Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.

Generation of an Induced Pluripotent Stem Cell Line SJTUXHi001-A from an Autism Spectrum Disorder Patient Carrying a Heterozygous Mutation in HDAC8 (P.p359s)

Establishment of Induced Pluripotent Stem Cell Line (Zzui010-A) from an Alzheimer's Disease Patient Carrying an APP Gene Mutation.

Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi051-A from an autism spectrum disorder patient with compound CHD8 gene mutations

Generation and characterization of human-derived iPSC lines from one pair of dizygotic twins discordant for schizophrenia.

Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids

Generation of a human induced pluripotent stem cell line (FDCHi012-A) from a patient with DYRK1A-related intellectual disability syndrome carrying DYRK1A mutation (c.1024G > T)

Derivation of Two Ipsc Lines from a Sporadic ASD Patient (Nuigi033-A) and a Paternal Control (Nuigi034-A).

Establishment of a non-integrated iPS cell line (SDQLCHi072-A) from a patient suffered from AUTS2 syndrome

Dysregulation of Neuron Differentiation in an Autistic Savant with Exceptional Memory.

Generation of an Integration-Free Induced Pluripotent Stem Cell (ipsc) Line (Zzuneui002-A) from a Patient with Spinocerebellar Ataxia Type 3.

Generation and characterization of human-derived iPSC lines from two cousins with schizophrenia and bipolar disorder and their unaffected cousin

Derivation of Four Ipsc Lines from a Male ASD Patient Carrying a Deletion in the Middle Coding Region of NRXN1α Gene (Nuigi039-a and NUIGi039-B) and a Male Sibling Control (Nuigi040-a and NUIGi040-B)

Altered Proliferation and Networks in Neural Cells Derived from Idiopathic Autistic Individuals

Human pluripotent stem cell (hPSC) and organoid models of autism: opportunities and limitations

Derivation of Ipsc Lines from Two Patients with Autism Spectrum Disorder Carrying NRXN1α Deletion (Nuigi041-A, NUIG041-B; NUIGi045-A) and One Sibling Control (Nuigi042-A, NUIGi042-B)